MAPK3 and breast cancer: We demonstrate herein, for the first time, that S1P2 is shed from breast cancer cells in exosomes and, when exposed to fibroblasts, is processed to a shorter form and taken up by these cells, whereupon it promotes activation of the ERK-1/2 pathway and stimulates proliferation of these cells.